Ten open questions in migraine prophylaxis with monoclonal antibodies blocking the calcitonin-gene related peptide pathway: a narrative review

The monoclonal antibodies (mAbs) blocking the calcitonin-gene related peptide (CGRP) pathway, collectively called here “anti-CGRP/rec mAbs”, have dramatically improved preventive migraine treatment. Although their efficacy and tolerability were proven in a number of randomized controlled trials (RCT...

Descripción completa

Detalles Bibliográficos
Autores principales: Schoenen, Jean, Van Dycke, Annelies, Versijpt, Jan, Paemeleire, Koen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391994/
https://www.ncbi.nlm.nih.gov/pubmed/37528353
http://dx.doi.org/10.1186/s10194-023-01637-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391994/
https://www.ncbi.nlm.nih.gov/pubmed/37528353
http://dx.doi.org/10.1186/s10194-023-01637-7

Ejemplares similares